Division of Medical Oncology, Department of Biomedicine, Basel University, Basel, Switzerland.
PLoS One. 2012;7(1):e29743. doi: 10.1371/journal.pone.0029743. Epub 2012 Jan 3.
Bone metastasis is a main cause of morbidity in breast cancer. Since breast cancer is a heterogeneous disease, the interactions of cancer cells with the skeletal host cells might also be diverse. We hypothesized that gene expression signatures induced by heterotypic interaction of breast cancer cells and osteoblasts might be of clinical relevance.
METHODOLOGY/PRINCIPAL FINDINGS: We established an ex vivo co-culture model using benign breast epithelial cells or a panel of 5 malignant breast epithelial cells in combination with primary human osteoblasts and determined associated gene expression changes with HEEBO microarrays. Pretreatment gene expression profiles of 295 early stage breast cancers published from the Netherlands Cancer Institute with a median follow up of 12.6 years allowed evaluating in vitro effects in the in vivo situation.The effects of the interaction between osteoblasts and breast cancer cell lines of different origin were very heterogeneous. Hs578T cells started to proliferate in co-culture with osteoblasts, SKBR-3 induced a TGF-β response and MDA-MB231 cells showed two distinct sets of up-regulated genes: A set of interferon response genes associated with an up-regulation of STAT1 was in vivo remarkably coherent providing a basis for segregation of tumors into two groups. In a uni-variate analysis, early stage tumors with high expression levels (n = 136) of this gene set had a significantly lower overall survival rate (p = 0.005) (63% at 10 years) than tumors with low expression levels (n = 159) (overall survival: 77% at 10 years). The second gene set was associated with IL-6 and did not significantly change the overall survival rate (p = 0.165), but was significantly associated with a shorter time to bone metastasis (p = 0.049; 74% vs. 83% at 10 years).
CONCLUSION/SIGNIFICANCE: An IL-6 gene expression pattern induced by heterotypic interaction of breast cancer cells with osteoblasts in vitro is associated with a higher rate of bone metastasis in vivo.
骨转移是乳腺癌发病率的主要原因。由于乳腺癌是一种异质性疾病,癌细胞与骨骼宿主细胞的相互作用也可能多种多样。我们假设,由乳腺癌细胞与成骨细胞的异质相互作用诱导的基因表达特征可能具有临床相关性。
方法/主要发现:我们建立了一个使用良性乳腺上皮细胞或一组 5 种恶性乳腺上皮细胞与原代人成骨细胞组合的体外共培养模型,并使用 HEEBO 微阵列确定了相关的基因表达变化。使用荷兰癌症研究所发表的 295 例早期乳腺癌的预处理基因表达谱(中位随访时间为 12.6 年),评估了体外作用在体内的情况。成骨细胞和乳腺癌细胞系之间相互作用的影响非常不同。Hs578T 细胞在与成骨细胞共培养时开始增殖,SKBR-3 诱导 TGF-β 反应,而 MDA-MB231 细胞则显示出两组上调的基因:一组与 STAT1 上调相关的干扰素反应基因,在体内显著一致,为肿瘤分为两组提供了基础。在单变量分析中,具有高表达水平(n=136)的该基因集的早期肿瘤总生存率(p=0.005)(10 年时为 63%)明显低于低表达水平的肿瘤(n=159)(总生存率:10 年时为 77%)。第二个基因集与 IL-6 相关,并未显著改变总生存率(p=0.165),但与骨转移时间较短显著相关(p=0.049;10 年时为 74%对 83%)。
结论/意义:体外乳腺癌细胞与成骨细胞的异质相互作用诱导的 IL-6 基因表达模式与体内更高的骨转移率相关。